Azilsartan clinical trials
Also written TAK-536.
How each study uses azilsartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the azilsartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
22 studies that test it; most in 2015 (5)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 5
Takeda (12) · Lee's Pharmaceutical Limited (3) · Celltrion (1) · Sogo Rinsho Médéfi Co., Ltd. (1) · Nara Medical University (1) · National Medical Research Center for Therapy and Preventive Medicine (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Jiangsu HengRui Medicine Co., Ltd. (1)
Often tested with
Tested in the same studies.
Pioglitazone (2) · Rosuvastatin (1) · Valsartan (1) · Losartan (1) · Hydrochlorothiazide (1) · Amlodipine (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses azilsartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionRecruitingNot applicableNational Medical Research Center for Therapy and Preventive MedicineNCT07683585Written as Amlodipine + AzilsartanHow we know
- A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureCompletedPhase 3TakedaNCT04668157Written as TAK-536How we know
- Azilsartan in Patients With Diabetic Kidney Disease and HypertensionStatus unknownNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05753696Written as AzilsartanHow we know
- A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult VolunteersCompletedPhase 1CelltrionNCT05002244Written as CTL0801 (Azilsartan)How we know
- A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedPhase 3TakedaNCT02791438Written as AzilsartanHow we know
- A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric FormulationCompletedPhase 1TakedaNCT03434977Written as TAK-536How we know
- A Phase 1, Bio-equivalence Study of TAK-536 Pediatric FormulationCompletedPhase 1TakedaNCT03042299Written as TAK-536How we know
- Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedPhase 1Lee's Pharmaceutical LimitedNCT02786082Written as 20mg Azilsartan TabletsHow we know
- Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedPhase 3Lee's Pharmaceutical LimitedNCT02609490Written as Azilsartan tabletsHow we know
- Bioequivalence Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedPhase 1Lee's Pharmaceutical LimitedNCT03652792Written as Azilsartan (Zhaoke)How we know
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedPhase 4TakedaNCT02079805Written as AzilsartanHow we know
- A Bioequivalence Study of TAK-536 Pediatric FormulationCompletedPhase 1TakedaNCT02401464Written as TAK-536 TabletHow we know
- A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.WithdrawnPhase 4TakedaNCT02400775Written as AzilsartanHow we know
- A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedPhase 3TakedaNCT02451150Written as AzilsartanHow we know
- Azilsartan Circadian and Sleep PressureCompletedNot applicableSogo Rinsho Médéfi Co., Ltd.NCT01762501Written as AzilsartanHow we know
- Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT02407210Written as azilsartanHow we know
- Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive PatientsStatus unknownPhase 2/3Hospital General de México Dr. Eduardo LiceagaNCT02235519Written as Azilsartan 40 mg.How we know
- New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure LoweringCompletedPhase 4Nara Medical UniversityNCT01609959Written as AzilsartanHow we know
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedPhase 2TakedaNCT00762736Written as Pioglitazone and azilsartanHow we know
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedPhase 2TakedaNCT01289132Written as AzilsartanHow we know
See all 22 studies that test azilsartan →
Given beside what is tested · 1 — azilsartan is usual care or a partner of the new treatment
Codes
What other systems call azilsartan · ClinicalTrials.gg INT005122
- MeSH (NLM) C521273azilsartanOne source NLM
- UNII (FDA) F9NUX55P23AZILSARTANConfirmed FDA, NLM, Wikidata
- RxNorm 1091643Confirmed FDA, Wikidata
- Wikidata Q27074832azilsartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75107AzilsartanOne source FDA
- DrugBank DB21772One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C521273 | azilsartan | One source NLM |
| UNII (FDA) | F9NUX55P23 | AZILSARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1091643 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27074832 | azilsartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75107 | Azilsartan | One source FDA |
| DrugBank | DB21772 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.